clonidine has been researched along with 4(5)-2-(2,6-dimethylphenyl)ethylimidazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kärki, NT; Puurunen, J; Ruskoaho, H; Savola, JM | 1 |
Kaipiainen, S; Kärki, N; Puurunen, J; Ruskoaho, H; Savola, JM | 1 |
2 other study(ies) available for clonidine and 4(5)-2-(2,6-dimethylphenyl)ethylimidazole
Article | Year |
---|---|
Peripheral cardiovascular alpha- and beta-adrenergic effects of some hypotensive and bradycardic arylalkyl imidazole derivatives in the rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Cardiovascular System; Clonidine; Decerebrate State; Dose-Response Relationship, Drug; Electric Stimulation; Female; Heart; Imidazoles; In Vitro Techniques; Male; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1985 |
The cardiovascular effects of MPV 295 [4(5)-2-(2,6-dimethylphenyl)ethylimidazole], a new antihypertensive agent with alpha 2-adrenoceptor agonistic properties.
Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Blood Pressure; Brain; Cardiovascular System; Cats; Clonidine; Heart Rate; Imidazoles; Male; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1983 |